T1	Participants 75 115	patients with non-erosive reflux disease
T2	Participants 342 382	patients with non-erosive reflux disease
T3	Participants 550 710	Adults with a history of reflux symptoms, a negative endoscopy, and > or = 3 days of moderate to very severe heartburn in the 7 days before enrollment (N = 535)
T4	Participants 793 863	Patients with complete symptom relief then entered the on-demand phase
T5	Participants 1489 1524	non-erosive reflux disease patients
